FindTrial
Sign In

A study to observe the Effects of anti--Hypertensive drugs In pregnant women

Evaluation of Efficacy & Safety of Anti--Hypertensive Drugs In Pregnancy With Hypertension at a Tertiary Care Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012950
Enrollment
150
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pregnancy with hypertension

Interventions

None listed

Sponsors

B J Medical College and Civil Hospital
Lead Sponsor
Dr Chandresh Dumatar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women with BP >= 140/90 mmHg. Patient willing to give written informed consent

Exclusion criteria

Exclusion criteria: Pregnant women with BP Patient not willing to give written informed consent

Design outcomes

Primary

MeasureTime frame
percentage of reduction of BPTimepoint: 4 months—

Secondary

MeasureTime frame
percentage of Adverse drug reactionsTimepoint: 4 months;percentage of IUGR and fetal distressTimepoint: 4 months;percentage of low birth weight babiesTimepoint: 4 months;percentage of maternal deathsTimepoint: 4 months;percentage of patients developing eclampsiaTimepoint: 4 months;percentage of perinatal deathsTimepoint: 4 months;percentage of preterm labourTimepoint: 4 months—

Countries

India

Contacts

Public ContactDr Kinjal Ninama

B J Medical College

drdumatar@gmail.com9426745911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026